Needham analyst Gil Blum maintains Gamida Cell (NASDAQ:GMDA) with a Buy and lowers the price target from $12 to $9.
Needham Maintains Buy on Gamida Cell, Lowers Price Target to $9
Needham analyst Gil Blum maintains Gamida Cell (NASDAQ:GMDA) with a Buy and lowers the price target from $12 to $9.
Related Posts
Barclays Maintains Overweight on Peloton Interactive, Lowers Price Target to $18
Barclays analyst Mario Lu maintains Peloton Interactive (NASDAQ:PTON) with a Overweight and lowers the price target from $22 to $18.
